Citations
2389 citation(s) found for "Lin, Yi".
Outcomes of Multiple Myeloma Patients Refractory to Standard Dose Vs Low Dose Lenalidomide
Goel, Utkarsh , Charalampous, Charalampos , Kapoor, Prashant , Fonder, Amie , Hayman, Suzanne R. , Hobbs, Miriam, Hwa, Yi L. , Kourelis, Taxiarchis , Lacy, Martha Q. , Lin, Yi , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Binder, Moritz , Buadi, Francis K. , Dingli, David , Dispenzieri, Angela , Gertz, Morie A. , Gonsalves, Wilson I. , Leung, Nelson , Rajkumar, S. Vincent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9998-9999
CAR-T Prescriber Preferences in Adolescents and Young Adults with B-ALL
Aquino, Victor , Hudspeth, Michelle, Rangarajan, Hemalatha G. , Anderson, Eric , Kelly, Susan, Ramachandran, Shanti , Lin, Yi , Kohorst, Mira A. , Godby, Richard , Ferdjallah, Asmaa , Alkhateeb, Hassan B. , Kitko, Carrie L. , Modi, Arunkumar J. , Katsanis, Emmanuel
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12762-12763
Early and Sustained Undetectable Measurable Residual Disease (MRD) after Idecabtagene Vicleucel (ide-cel) Defines a Subset of Multiple Myeloma (MM) Patients in Karmma Achieving Prolonged Survival
Manrique, Irene , Campbell, Timothy , Kazanecki, Christian C. , Martin, Nathan , Kaiser, Shari M. , Anderson, Larry D. , Lin, Yi , Munshi, Nikhil C. , Anderson, Larry D , Paiva, Bruno , Rytlewski, Julie , Berdeja, Jesús G. , Lonial, Sagar , Raje, Noopur , Moreau, Philippe , Miguel, Jesús F. San
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2104-2105
Outcomes of Axicabtagene Ciloleucel in Comparison with Chemoimmunotherapy (CIT) in an Elderly Population for Treatment of Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) after Two or More Lines of Prior Therapy
Lunning, Matthew A. , Wang, Hailin , Hu, Zhen‐Huan , Jacobson, Caron A. , Lin, Yi , Hill, Brian T. , Neelapu, Sattva S. , Miao, Harry , Shahani, Shilpa, Patel, Anik R. , Spooner, Clare, Fu, Christine, Xu, Hairong, Pasquini, Marcelo C. , Locke, Frederick L. , Siddiqi, Tanya , Ahmed, Sairah , Miklos, David B. , Ghobadi, Armin , Westin, Jason R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1852-1855
A Risk-Adapted Study to Assess the Efficacy of Enasidenib and Subsequent Response-Driven Addition of Azacitidine for Newly Diagnosed IDH2-Mutant AML Patients: 3-Year Follow-up
Stein, Eytan M. , Huang, Ying , Dunbar, Andrew , Baer, Maria R. , Kovacsovics, Tibor , Blum, William , Schiller, Gary J. , Olin, Rebecca L. , Foran, James M. , Litzow, Mark R. , Patel, Prapti A. , Boyiadzis, Michael , Collins, Robert H. , Chervin, Jordan , Vergilio, Jo‐Anne, Heerema, Nyla A. , Rosenberg, Leonard, Yocum, Ashley O. , Druggan, Franchesca , Marcus, Sonja, Stefanos, Mona , Martycz, Molly , Borate, Uma , Burd, Amy , Byrd, John C. , Byrd, John C , Cai, Sheng F , Stock, Wendy , Lin, Tara L. , Foster, Matthew C , Shoben, Abigail B. , Chen, Timothy Frank , Druker, Brian J , Mims, Alice S , Levine, Ross L.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2016-2019
Muscle and Fat Composition in Patients with Newly Diagnosed Multiple Myeloma
Abdallah, Nadine , Nagayama, Hiroki , Fonder, Amie , Lacy, Martha Q. , Hobbs, Miriam, Kapoor, Prashant , Warsame, Rahma , Hayman, Suzanne R. , Kourelis, Taxiarchis , Hwa, Yi L., Kyle, Robert A. , Kumar, Shaji , Takahashi, Naoki , Gonsalves, Wilson I. , Dispenzieri, Angela , Dingli, David , Buadi, Francis K. , Gertz, Morie A. , Binder, Moritz , Lin, Yi , Rajkumar, S. Vincent , Broski, Stephen M.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7141-7143
CDK7 Inhibition Targets Proliferative and Metabolic Oncogenic Vulnerabilities in Multiple Myeloma
Ng, Jessica Fong, Park, Woojun D. , Morelli, Eugenio , Kwiatkowski, Nicholas , Chyra, Zuzana , Chesi, Marta, Gray, Nathaniel, Young, Richard A., Lin, Charles Y., Munshi, Nikhil C. , Fulciniti, Mariateresa , Morelli, Eugenio , Chyra, Zuzana , Yao, Yao , Samur, Mehmet , Encinas, Jessica , Xu, Yan , Nabet, Behnam , Chesi, Marta , Anderson, Kenneth C.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9955-9956
Outcomes of Relapsed Refractory Double Hit Lymphoma: A Multicenter Observational Cohort
Khurana, Arushi , Hernandez‐Ilizaliturri, Francisco J. , Nizamuddin, Imran , Hatic, Haris, Landsburg, Daniel A, Lin, Yi , Isufi, Iris, Hill, Brian T. , Nowakowski, Grzegorz S. , Desai, Sanjal H. , Watkins, Marcus P. , Karmali, Reem , Goyal, Gaurav , Hughes, Mitchell E. , Sumransub, Nuttavut , Zurko, Joanna C. , Landsburg, Daniel, Anampa‐Guzmán, Andrea , Hamadani, Mehdi , Tun, Aung M. , Stephens, Deborah M. , Caimi, Paolo F. , Ermann, Daniel A. , Kahl, Brad S.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10391-10393
Efficacy of CD19 Directed Therapies in Large B-Cell Lymphoma (LBCL) Relapsing after Chimeric Antigen Receptor (CAR) T-Cell Therapy
Khurana, Arushi , Chavez, Julio, Craver, Emily C. , Aditi, Saha, Annunzio, Kaitlin , Isufi, Iris, Fijalka, Andrew, Sandoval‐Sus, Jose , Ivanov, Stanislav , Lin, Yi , Kharfan‐Dabaja, Mohamed A. , Saha, Aditi , Saha, Aditi , Iqbal, Madiha , Rosenthal, Allison , Li, Zhuo , Aditi, Saha, Epperla, Narendranath , Awan, Farrukh T. , Dholaria, Bhagirathbhai , Bhaskar, Shakthi , Maakaron, Joseph E. , Sumransub, Nuttavut
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10396-10398
Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6
Oluwole, Olalekan O. , Forcade, Édouard , Muñoz, Javier, Guibert, Sophie de , Lin, Yi , Deol, Abhinav , McSweeney, Peter A., Kersten, Marie José , Jacobson, Caron A. , Thiéblemont, Catherine , Timmerman, John M. , Stiff, Patrick J. , Tzachanis, Dimitrios , Zheng, Yan , Vardhanabhuti, Saran , Shen, Rhine R. , Miao, Harry , Kim, Jenny , Oluwole, Olalekan O , Vose, Julie M. , Bartlett, Nancy L. , Goy, Andre Henri , Farooq, Umar , Minnema, Monique C , Avivi, Irit , Nater, Jenny , Meerten, Tom van
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10399-10401